U.S. flag

An official website of the United States government

NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del) AND Malaria, cerebral, resistance to

Germline classification:
protective (1 submission)
Last evaluated:
Mar 1, 2009
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000019330.32

Allele description [Variation Report for NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del)]

NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del)

Gene:
SLC4A1:solute carrier family 4 member 1 (Diego blood group) [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q21.31
Genomic location:
Preferred name:
NM_000342.4(SLC4A1):c.1199_1225del (p.Ala400_Ala408del)
HGVS:
  • NC_000017.11:g.44258044_44258070del
  • NG_007498.1:g.15066_15092del
  • NM_000342.4:c.1199_1225delMANE SELECT
  • NP_000333.1:p.Ala400_Ala408del
  • LRG_803t1:c.1199_1225del
  • LRG_803:g.15066_15092del
  • LRG_803p1:p.Ala400_Ala408del
  • NC_000017.10:g.42335411_42335437del
  • NC_000017.10:g.42335412_42335438del
  • NC_000017.11:g.44258043_44258069del
  • NM_000342.2:c.1199_1225del
  • NM_000342.3:c.1199_1225del
  • NM_000342.3:c.1199_1225del27
  • p.Ala400_Ala408del
Note:
NCBI staff reviewed the sequence information reported in PubMed 1737855 Fig. 2 to determine the location of this allele on the current reference sequence.
Links:
OMIM: 109270.0002; dbSNP: rs769664228
NCBI 1000 Genomes Browser:
rs769664228
Molecular consequence:
  • NM_000342.4:c.1199_1225del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Malaria, cerebral, resistance to
Identifiers:
MedGen: C1969379

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000039620OMIM
no assertion criteria provided
protective
(Mar 1, 2009)
germlineliterature only

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Molecular defect of the band 3 protein in southeast Asian ovalocytosis.

Liu SC, Zhai S, Palek J, Golan DE, Amato D, Hassan K, Nurse GT, Babona D, Coetzer T, Jarolim P, et al.

N Engl J Med. 1990 Nov 29;323(22):1530-8.

PubMed [citation]
PMID:
2146504
See all PubMed Citations (10)

Details of each submission

From OMIM, SCV000039620.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (10)

Description

Following up on the demonstration by Liu et al. (1990) that a structurally and functionally abnormal band 3 protein shows absolute linkage with the SAO phenotype (166900), Jarolim et al. (1991) demonstrated that the EPB3 gene in these cases contains a 27-bp deletion, resulting in deletion of 9 amino acids (codons 400-408) in the boundary of cytoplasmic and membrane domains of the band 3 protein. The defect was detected in all 30 ovalocytic subjects from Malaysia, the Philippines, and 2 unrelated coastal regions of Papua New Guinea, whereas it was absent in all 30 controls from Southeast Asia and 20 subjects of different ethnic origin from the United States. The lys56-to-glu mutation (109270.0001) was also found in all SAO subjects; however, it was detected in 5 of 50 control subjects as well, suggesting that it represents a linked polymorphism.

Mohandas et al. (1992) likewise demonstrated the deletion of amino acids 400-408 in the boundary between the cytoplasmic and the first transmembrane domains of band 3. The biophysical consequences of the mutation was a marked decrease in lateral mobility of band 3 and an increase in membrane rigidity. Mohandas et al. (1992) suggested that the mutation induces a conformational change in the cytoplasmic domain of band 3, leading to its entanglement in the skeletal protein network. This entanglement inhibits the normal unwinding and stretching of the spectrin tetramers necessary for membrane extension, leading to increased rigidity.

The same deletion of 9 amino acids was found by Tanner et al. (1991) in a Mauritian Indian and by Ravindranath et al. (1994) in an African American mother and daughter. All cases of SAO had been associated with the Memphis-1 polymorphism (109270.0001), which is found in all populations but is present at higher frequency in American Indian and African American populations. However, SAO had not previously been identified in African Americans.

The band 3 deletion in Southeast Asian ovalocytosis may prevent cerebral malaria (611162), but it exacerbates malarial anemia and may also increase acidosis, a major determinant of mortality in malaria. Allen et al. (1999) undertook a case-control study of children admitted to hospital in a malarious area of Papua New Guinea. The 24-bp deletion, detected by PCR, was present in 0 of 68 children with cerebral malaria, compared with 6 (8.8%) of 68 matched community controls. Median hemoglobin levels were 1.2 g/dl lower in malaria cases with Southeast Asian ovalocytosis than in controls (P = 0.035), but acidosis was not affected. The band 3 protein mediates the cytoadherence of parasitized erythrocytes in vitro. The remarkable protection that the SAO variant affords against cerebral malaria may offer a valuable approach to a better understanding of the mechanisms of adherence of parasitized erythrocytes to vascular endothelium and the pathogenesis of cerebral malaria.

The abnormal SAO protein does not mediate chloride transport (Groves et al., 1993), and homozygosity for the 9-amino acid deletion is apparently lethal (Liu et al., 1994).

Yusoff et al. (2003) examined the incidence of SAO in Malays in Kelantan, Malaysia, who had distal renal tubular acidosis. SAO was identified in 18 of the 22 distal renal tubular acidosis patients (81.8%), but in only 2 of the 50 controls (4%). Yusoff et al. (2003) referred to the band 3 variant as a 27-nt deletion.

In a population-based study of 19 individuals each from Japan, Taiwan, and Indonesia, Wilder et al. (2009) found the 27-bp deletion associated with the SAO trait in 4 of the Indonesian samples only. These 4 SAO chromosomes also carried the Memphis variant (109270.0001). The haplotype associated with the 27-bp deletion was also found in Japanese samples, but not in Taiwanese samples, which was a surprising finding since Taiwan was thought to be part of the Austronesian population expansion. The findings indicated that chromosomes related to Indonesian SAO alleles are not a major component of genetic diversity among aboriginal Taiwanese, and suggested that the SLC4A1 gene is subject to natural selection.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024